• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Research on tumor microenvironment modification by combined use of metformin and fasting

Research Project

Project/Area Number 21K19409
Research Category

Grant-in-Aid for Challenging Research (Exploratory)

Allocation TypeMulti-year Fund
Review Section Medium-sized Section 50:Oncology and related fields
Research InstitutionOkayama University

Principal Investigator

Udono Heiichiro  岡山大学, 医歯薬学域, 教授 (50260659)

Co-Investigator(Kenkyū-buntansha) 工藤 生  岡山大学, 医歯薬学域, 助教 (40830378)
西田 充香子  岡山大学, 医歯薬学域, 助教 (60844644)
Project Period (FY) 2021-07-09 – 2024-03-31
Project Status Completed (Fiscal Year 2023)
Budget Amount *help
¥6,500,000 (Direct Cost: ¥5,000,000、Indirect Cost: ¥1,500,000)
Fiscal Year 2023: ¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000)
Fiscal Year 2022: ¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000)
Fiscal Year 2021: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
Keywords腫瘍血管 / 代謝 / 一酸化窒素 / 腫瘍浸潤CD8T細胞 / インターフェロンγ / 低酸素 / 腫瘍浸潤T細胞
Outline of Research at the Start

胃がん、肺がんなどの固形腫瘍の治療では、これまでに標準治療と呼ばれてきた手術療法、化学療法、放射線療法の3つに加えて新たに免疫治療が認められた。免疫治療では免疫チェックポイント阻害薬を中心に化学療法を組み合わせるなどの方法が現在行われており、相当の効果を見る場合もあることが確認されている。免疫療法ではがんを退縮に追い込むエフェクター細胞に加え、樹状細胞やNK細胞などの一連の細胞集団が腫瘍塊に多く入り込み、そこで長く生存することが必要である。そのためには腫瘍局所の低酸素、低グルコース、低pHを改善してやることが必要である。メトホルミンと間歇的な絶食法がこれを可能にできるかもしれない。

Outline of Final Research Achievements

It has been reported that when cancer patients undergo intermittent fasting, their tumors may shrink in occasion. We recently found that the combination of fasting and metformin treatment may have a strong antitumor effect, compared to monotherapy alone. In this study, we were able to clarify part of the underlying molecular mechanism. The excellent antitumor effect observed when metformin is combined with fasting is due to normalization the tumor vessels via suppression of glycolysis in tumor vascular endothelial cells, and the enhanced infiltration of CD8T lymphocytes to tumor due to oxygenation of the tumor microenvironment (reduction in HIF1α expression) associated with blood vessel normalization. The main causes were thought to be an increase in the influx of CD8T cells (CD8TIL), their enhanced interferon γ production, and a decrease in the number of Foxp3+ cells.

Academic Significance and Societal Importance of the Research Achievements

癌患者が間歇的絶食を行うことで腫瘍が縮小する場合があることが報告されている。癌細胞にグルコースをはじめとする栄養素を与えないとする兵糧攻めがそのメカニズムの一つだと考えられている。我々の今回の研究は、絶食にメトホルミン投与を併用することで、より強力な抗腫瘍効果を発揮する可能性を新たに見出した。その分子機構の一端として、腫瘍血管内皮細胞の正常化、それに伴う腫瘍微小環境の酸素化、さらには免疫CD8T細胞の腫瘍への流入増加とインターフェロンγ産生の亢進、制御性T細胞の減少が主な原因である事が示された。間歇的絶食による抗腫瘍効果メカニズムの理解を助けるに資するエビデンスを得ることができた。

Report

(2 results)
  • 2023 Final Research Report ( PDF )
  • 2022 Research-status Report
  • Research Products

    (10 results)

All 2023 2022

All Journal Article (6 results) (of which Peer Reviewed: 6 results,  Open Access: 6 results) Presentation (4 results) (of which Invited: 4 results)

  • [Journal Article] Nutrient condition in the microenvironment determines essential metabolisms of CD8+T cells for enhanced IFNg production by metformin.2022

    • Author(s)
      Ruoyu C, Nishida M, Yamashita N, Tokumasu M, Zhao W, Kudo I, Udono H.
    • Journal Title

      Frontiers in Immunology

      Volume: 13 Pages: 864225-864225

    • DOI

      10.3389/fimmu.2022.864225

    • Related Report
      2022 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Metformin-ROS-Nrf2 connection in the host defense mechanism against oxidative stress, apoptosis, cancers, and ageing.2022

    • Author(s)
      Udono H, Nishida M.
    • Journal Title

      Biochimica et Biophysica Acta (BBA) - General Subjects.

      Volume: 1866 Issue: 8 Pages: 130171-130171

    • DOI

      10.1016/j.bbagen.2022.130171

    • Related Report
      2022 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] CD8+ T-cell responses are boosted by dual PD-1/VEGFR2 blockade after EGFR inhibition in Egfrmutant lung cancer.2022

    • Author(s)
      Nishii K, Ohashi K, Tomida S, Nakasuka T, Hirabae A,Okawa S, Nishimura J, Higo H, Watanabe H, Kano H, Ando C, Makimoto G, Ninomiya K, Kato Y, Kubo T, Ichihara E, Hotta K, Tabata M, Toyooka S, Udono H, Maeda Y, Kiura K.
    • Journal Title

      Cancer Immunol Res.

      Volume: 10 Issue: 9 Pages: 1111-1126

    • DOI

      10.1158/2326-6066.cir-21-0751

    • Related Report
      2022 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Blocking EP4 down-regulates tumor metabolism and synergizes with anti-PD-1 therapy to activate natural killer cells in a lung adenocarcinoma model.2022

    • Author(s)
      Tokumasu M, Nishida M, Kawaguchi T, Kudo I, Kotani T, Takeda K, Yoshida T, Udono H.
    • Journal Title

      International Immunology

      Volume: 34 Issue: 6 Pages: 293-302

    • DOI

      10.1093/intimm/dxac004

    • Related Report
      2022 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Pharmacological effects on anaplerotic pathways alters the metabolic landscape in the tumor microenvironment, causing unpredictable, sustained antitumor immunity.2022

    • Author(s)
      Udono H , Nishida M
    • Journal Title

      International immunology

      Volume: 34 Issue: 3 Pages: 133-140

    • DOI

      10.1093/intimm/dxab067

    • Related Report
      2022 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Metformin ameliorates chronic colitis in a mouse model by regulating. interferon-γ-producing lamina. propria CD4 + T cells through AMPK activation2022

    • Author(s)
      Takahara Masahiro
    • Journal Title

      FASEB

      Volume: Feb;36(2) Issue: 2

    • DOI

      10.1096/fj.202100831rr

    • Related Report
      2022 Research-status Report
    • Peer Reviewed / Open Access
  • [Presentation] 活性酸素が拓く生体防御機能2023

    • Author(s)
      鵜殿平一郎
    • Organizer
      第16回 NPO 健康医療開発機構シンポジウム
    • Related Report
      2022 Research-status Report
    • Invited
  • [Presentation] 活性酸素が拓く生体防御機能と健康長寿2022

    • Author(s)
      鵜殿平一郎
    • Organizer
      第20回四国免疫フォーラム
    • Related Report
      2022 Research-status Report
    • Invited
  • [Presentation] 活性酸素が拓く生体防御機能と健康寿命2022

    • Author(s)
      鵜殿平一郎
    • Organizer
      第26回 日本バイオ治療法学会学術集会
    • Related Report
      2022 Research-status Report
    • Invited
  • [Presentation] IFNγ依存性の腫瘍代謝改変と腫瘍血管正常化2022

    • Author(s)
      鵜殿平一郎
    • Organizer
      鶴岡カンファレンス2022
    • Related Report
      2022 Research-status Report
    • Invited

URL: 

Published: 2021-07-13   Modified: 2025-01-30  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi